Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100

2008607 citationsJournal Articlebronze Open Access

Authors

Bryan P. Schneider

Μolin Wang

Abstract

Our data support an association between VEGF genotype and median OS as well as grade 3 or 4 hypertension when using bevacizumab in metastatic breast cancer.

Topics & Keywords

Angiogenesis and VEGF in Cancer Cancer Treatment and Pharmacology Breast Cancer Treatment Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 26, Issue 28, pp. 4672-4678

DOI: 10.1200/jco.2008.16.1612

Field-Weighted Citation Impact: 29.49